Two cutoff values, i.e., 400 pg/ml (92% sensitivity and 60% specificity) and 1,200 pg/ml (84% sensitivity and 87%), for IL-6 has been evaluated for stage I and stage II ovarian cancer subjects. This evidence concerns the gene IL6 and ovarian carcinoma.